To understand bone marrow failure and identify new treatments, detailed knowledge on how different types of blood cells are formed is essential. This work aimed to answer two fundamental questions: ‘What genes determine the proportion of specific cell types in the blood?’ and ‘What are the underlying genetic drivers for gene expression in different blood cells?’.
Over 1000 blood samples and 72 bone marrow samples from Tasmanians were subjected to in-depth analysis to gain a deeper understanding of how genetic differences between people affect the development of blood cells. Several publications have resulted from this work, helping to predict how genetic variants affect the severity of bone marrow failure and providing important information on potential new targets for treatment.
2023- 2025 (Fellowship): Discovery of novel niche factors to improve long-term stem cell transplantation in bone marrow failure syndromes. Dr Vashe Chandrakanthan, The University of Adelaide. For many patients with Bone Marrow Failure Syndromes, ...
Read more2022-2025 (Fellowship): Dissecting immune dysregulation in acquired Bone Marrow Failure Syndromes to identify new therapeutic leads. Associate Professor Rachel Koldej, ACRF Translational Research Laboratory, Melbourne Health. Bone Marrow Failure ...
Read more2021-2024 (Fellowship): Improving outcomes for Australian patients and families with bone marrow failure related diseases through comprehensive clinicogenomic care and collaborative research. Dr Lucy Fox, Peter MacCallum Cancer Centre. Dr Lucy ...
Read more2018-2021 (Doctoral Degree Fellowship): Clinical, genomic and molecular determinants of outcome in patients with Bone Marrow Failure Syndromes, Dr Lucy Fox, The University of Melbourne. This project is the first scholarship in Australia to ...
Read more